Abstract
Cyclosidimine is a new vasodilator drug with a direct action on vascular smooth muscle. Oral administration of 2.5, 5.0 and 7.5 mg in five normal volunteers had no effect on blood pressure in the supine position but reduced systolic and diastolic pressure in the erect position. In both positions heart rate was significantly greater after cyclosidimine than after placebo. Propranolol prevented the increases in heart rate produced by cyclosidimine which then produced greater reductions in blood pressure.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blumental H. P., Ryan J. R., McMahon F. G. Initial clinical experience with a new peripheral vasodilator, PR-G-138-Cl, in hypertensive patients. Eur J Clin Pharmacol. 1975 Aug 14;8(6):409–414. doi: 10.1007/BF00562314. [DOI] [PubMed] [Google Scholar]
- Nicholls D. P., Harron D. W., Shanks R. G. Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man. Br J Clin Pharmacol. 1983 Jan;15(1):21–29. doi: 10.1111/j.1365-2125.1983.tb01458.x. [DOI] [PMC free article] [PubMed] [Google Scholar]